Xcell Therapeutics Inc. (KOSDAQ:373110)
1,773.00
-24.00 (-1.34%)
Apr 29, 2026, 3:30 PM KST
-52.78% (1Y)
| Market Cap | 30.66B |
| Revenue (ttm) | 1.95B |
| Net Income (ttm) | -10.93B |
| Shares Out | 17.29M |
| EPS (ttm) | -938.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 154,016 |
| Average Volume | 315,022 |
| Open | 1,802.00 |
| Previous Close | 1,797.00 |
| Day's Range | 1,750.00 - 1,841.00 |
| 52-Week Range | 1,301.00 - 4,120.00 |
| Beta | n/a |
| RSI | 68.97 |
| Earnings Date | Apr 13, 2026 |